Single-step bioassays in serum and whole blood with a smartphone, quantum dots and paper-in-PDMS chips

The development of nanoparticle-based bioassays is an active and promising area of research, where point-of-care (POC) diagnostics are one of many prospective applications. Unfortunately, the majority of nanoparticle-based assays that have been developed to date have failed to address two important...

Ausführliche Beschreibung